Skip to content

HGH 191AA (Somatotropin)

FDA-approved context Growth Hormone 3 sources

HGH 191AA, also known as Somatotropin, is a bio-identical synthetic version of human growth hormone containing exactly 191 amino acids. Research demonstrates its critical role in cellular regeneration, growth, metabolism, and maintaining healthy human tissue throughout the lifespan.

01Dosing reference

Amount
1-2 IU per day (for anti-aging/wellness); up to 4-6 IU per day (for severe deficiency or muscle wasting)
Frequency
Once daily, typically administered via subcutaneous injection in the evening or before bed
Cycle
Continuous for clinical deficiency; 3-6 month cycles for other research applications
Reference figures, not a recommendationThese values reflect amounts described in the literature and vendor documentation this database indexes. Use the reconstitution calculator to convert them into syringe units.

02Mechanism of action

01

Receptor Binding

Binds directly to growth hormone receptors (GHR) located on the surface of target cells across various tissues.

02

IGF-1 Stimulation

Stimulates the liver and other tissues to secrete Insulin-like Growth Factor 1 (IGF-1), which mediates many of its systemic effects.

03

Metabolic and Anabolic Action

Promotes lipolysis (fat breakdown), increases protein synthesis, and stimulates the growth of bone and cartilage.

03Human evidence

Significant improvement in body composition, including increased lean body mass and decreased fat mass, in adults with growth hormone deficiency.

Multiple randomized controlled trials in adults diagnosed with severe GH deficiency.

Increased bone mineral density and reduced fracture risk over long-term replacement therapy.

Longitudinal studies tracking patients on GH replacement therapy for up to 10-15 years.

04Preclinical evidence

Enhanced tissue regeneration and wound healing in various injury models.

Animal models of severe burns and surgical wounds.

Neuroprotective effects and promotion of neurogenesis in the central nervous system.

Rodent models investigating brain injury and age-related cognitive decline.

05What is known vs. unknown

Reasonably established
  • Bio-identical to the naturally occurring growth hormone produced by the human pituitary gland.
  • Acts both directly on tissues and indirectly through the stimulation of IGF-1.
  • Clinically proven to treat growth hormone deficiency in both pediatric and adult populations.
  • Known to improve lipid profiles and cardiovascular risk markers in deficient individuals.
Unknowns & limits
  • The long-term safety of supraphysiological doses used for anti-aging or performance enhancement remains poorly documented.
  • The exact relationship between long-term exogenous GH use and the risk of developing certain neoplasms (cancers) is still debated.

06Safety & regulatory context

Regulatory statusSomatropin (HGH 191AA) is FDA-approved for specific medical indications, including pediatric and adult growth hormone deficiency, Turner syndrome, and HIV-associated wasting. However, its off-label distribution or use for anti-aging, bodybuilding, or athletic performance enhancement is strictly regulated and often illegal. Common side effects include fluid retention (edema), joint and muscle pain, carpal tunnel syndrome, and impaired glucose tolerance or insulin resistance.

07Compared with Ipamorelin

HGH 191AA (Somatotropin) vs. Ipamorelin
Key difference
HGH 191AA is an exogenous replacement of the hormone itself, whereas Ipamorelin is a secretagogue that stimulates the pituitary gland to produce more of its own natural growth hormone.
When researchers discuss each
HGH is discussed when profound, direct hormone replacement is clinically necessary, while Ipamorelin is researched for its ability to provide a milder, pulsatile increase in GH with a lower risk of side effects like insulin resistance.

08Glossary

Somatotropin
The scientific name for growth hormone, a peptide hormone that stimulates growth, cell reproduction, and cell regeneration.
IGF-1 (Insulin-like Growth Factor 1)
A hormone produced primarily by the liver in response to growth hormone, responsible for many of the growth-promoting effects of HGH.
Lipolysis
The metabolic process of breaking down lipids (fats) into free fatty acids and glycerol, which is stimulated by growth hormone.

09Knowledge check

Q1How does HGH 191AA primarily exert its anabolic and growth-promoting effects on tissues?
Q2Which of the following is a well-documented side effect of exogenous HGH administration?
Q3Which statement best reflects a documented limitation in the evidence about long-term exogenous use of HGH 191AA?
Q4According to the dossier, which best distinguishes HGH 191AA from Ipamorelin in research focus?
Q5Which statement accurately reflects the regulatory and safety context provided for Somatropin (HGH 191AA)?

10Sources

More in Growth Hormone

See all
Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.